John Kelly:
SVP, TORL Biotherapeutics, LLC
About John Kelly:
I am an alum of Vanderbilt University. Since 2020, I have been working on two drug discovery platforms spun out of Caltech and UCLA. The past few years I have focused my efforts on helping build TORL Biotherapeutics, an ADC platform spun out of UCLA. My responsibilities have included raising equity financing through three venture rounds from leading life science investors. Prior to getting involved with university spinouts, I spent almost two decades in various investment management roles across asset classes.
To meet with John, or any of our excellent mentors, please fill out this interest form.